Publication date: October 2026 Source: American Journal of Obstetrics and Gynecology, Volume 235, Issue 4 Author(s): Yang Zhang, Sifan Sun, Hailiang Fang
Preimplantation genetic testing for aneuploidy mosaicism reporting lacks clinical predictive value for live birth (letter to the editor). // American Journal of Obstetrics & Gynecology. – URL: https://www.sciencedirect.com/science/article/pii/S0002937826003029?dgcid=rss_sd_all
Preimplantation genetic testing for aneuploidy mosaicism reporting lacks clinical predictive value for live birth (letter to the editor). American Journal of Obstetrics & Gynecology. https://www.sciencedirect.com/science/article/pii/S0002937826003029?dgcid=rss_sd_all
“Preimplantation genetic testing for aneuploidy mosaicism reporting lacks clinical predictive value for live birth (letter to the editor).” American Journal of Obstetrics & Gynecology.
@article{article106665,
title = {Preimplantation genetic testing for aneuploidy mosaicism reporting lacks clinical predictive value for live birth (letter to the editor)},
journal = {American Journal of Obstetrics \& Gynecology},
url = {https://www.sciencedirect.com/science/article/pii/S0002937826003029?dgcid=rss_sd_all}
}
ABSTRACT Introduction Postpartum hemorrhage (PPH) has significant short‐ and long‐term effects for women. Research typically focuses on women who experience severe bleeding. Little is known about women's understanding of their risk or...